1. Agnello L, Scazzone C, Lo Sasso B, Bellia C, Bivona G, Realmuto S, Brighina F, Schillaci R, Ragonese P, Salemi G, Ciaccio M. VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients. Biochem Genet 2017 Apr; 55 (2): 183-192.
2.
Aihara M. Pharmacogenetics of cutaneous adverse drug reactions. J Dermatol 2011; 38: 246-254.
3.
Bouvresse S, Khosrotehrani K, Aouizerate F, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) – a descriptive study of 25 cases. Journal of the American Academy of Dermatology 2010; 62 (2): 205-211.
4.
Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010 Dec; 146 (12): 1373-1379.
5.
Chen YC, Cho YT, Chang CY, Chu CY. Drug reaction with eosinophilia and systemic symptoms: A drug-induced hypersensitivity syndrome with variable clinical features. Dermatologica Sinica 2013; 31 (4): 196-204.
6.
Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci 2017 Jun 9; 18 (6).
7.
Dahlin D, Miwa G, Lu A, Nelson S. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 1984 Mar; 81 (5): 1327-31.
8.
Descamps V, Ranger-Rogez S. DRESS syndrome. Joint Bone Spine. 2014 Jan; 81 (1): 15-21.
9.
Ghozlane L, Asma J, Ahmed Z, Ons C, Sarrah K, Riadh D, Sihem EA. Antipsychotics Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Literature Review and a Report of a Suspected Case Related to Chlorpromazine. Curr Drug Saf 2023; 18 (4): 571-575.
10.
Gupta S, Deep R, Khandelwal SK, Khaitan BK, Nishanth KN. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient with Bipolar Disorder: A Case Report. Indian J Psychol Med 2021 May; 43 (3): 269-270.
11.
Hassine H, Ouali U, Ouertani A, Jomli R, Nacef F. Clozapine-induced DRESS syndrome with multiple and rare organ involvement. Asian J Psychiatr 2017 Aug; 28: 146-147.
12.
Hese RT. Wskazania do stosowania EW. W: Hese RT, Zyss T.: Elektrowstrząsy w praktyce klinicznej. Elsevier – Wydawnictwo Medyczne Urban & Partner. Wrocław 2007: 54-58.
13.
Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand. Allergol Int 2016 Oct; 65 (4): 432-438.
14.
Jaffe R. The Practice of Electroconvulsive Therapy. Recomendations for Treatment, Training, and Privileging. A task Force Report of the American Psychiatric Association. APA, Washington 2001.
15.
Kano Y, Hiraharas K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006 Aug; 155 (2): 301-306.
16.
Kerr B, Thummel K, Wurden C, Klein S, Kroetz D, Gonzalez F, Levy R. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 1994 Jun 1; 47 (11): 1969-79.
17.
Krylov I, Krynetskiĭ E, Maruzhenkov D, Prokhorov B. Dinamika raspredeleniia i metabolizm prednizolona i deksametazona v organizme belykh krys [The dynamics of prednisolone and dexamethasone distribution and metabolism in the body of white rats]. Farmakol Toksikol 1991 Jul-Aug; 54 (4): 50-3.
18.
Kuyucu S, Caubet JC. Hypersensitivity reactions to antiepileptic drugs in children: epidemiologic, pathogenetic, clinical, and diagnostic aspects. J Allergy Clin Immunol Pract 2018 Nov; 6 (6): 1879-1891.
19.
Moazez C, Rudha Y, Narang N, Younger T. A Rare Presentation of Clozapine-Induced DRESS Syndrome. Case Rep Med 2018 Jun 11; 2018: 1346351.
20.
Oriolo G, Brugués A, Pintor L, Goikolea JM. Lamotrigine induced dress syndrome in bipolar disorder. Actas Esp Psiquiatr 2017 May; 45 (3): 127-36.
21.
Prescott L. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol 1980 Oct;10 Suppl 2 (Suppl 2): 291S-298S.
22.
Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management Expert Opin Drug Saf 2016: 1-9.
23.
Shiohara T, Kano Y, Takahashi R, Ishida T, Mizukawa Y. Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Chem Immunol Allergy 2012 May 3; 97: 122-138.
24.
Wolf R, Matz H, Marcos B, Orion E. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. Clin Dermatol 2005 May-Jun; 23 (3): 311-4.
25.
Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995 May; 131 (5): 544-551.
